Literature DB >> 744677

An improper use of statistical significance testing in studying covariables.

L G Dales, H K Ury.   

Abstract

How badly a covariable confounds the association between a disease and a primary trait depends on the strength of two other associations: between covariable and disease, and between covariable and primary trait. To assess the confounding potential by testing one of these associations for statistical significance, using a 'traditional' critical level, is inadequate. Such a preliminary test places the burden of proof in the wrong direction, ignores a major aspect of confounding potential, and may be inappropriately influenced by other factors. If it must be used at all, the significance level should be 0.25 or 0.50, possibly even higher.

Mesh:

Year:  1978        PMID: 744677     DOI: 10.1093/ije/7.4.373

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  37 in total

1.  John Henryism and Perceived Health among Hemodialysis Patients in a Multiracial Brazilian Population: the PROHEMO.

Authors:  Gildete Barreto Lopes; Sherman A James; Marcelo Barreto Lopes; Carolina Cartaxo Penalva; Camila Tavares Joau E Silva; Cacia Mendes Matos; Márcia Tereza Silva Martins; Antonio Alberto Lopes
Journal:  Ethn Dis       Date:  2018-10-18       Impact factor: 1.847

2.  Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week.

Authors:  Matthew Laughon; Carl Bose; Elizabeth Allred; T Michael O'Shea; Linda J Van Marter; Francis Bednarek; Alan Leviton
Journal:  Pediatrics       Date:  2007-02       Impact factor: 7.124

3.  Extremely low gestational age and very low birthweight for gestational age are risk factors for autism spectrum disorder in a large cohort study of 10-year-old children born at 23-27 weeks' gestation.

Authors:  Robert M Joseph; Steven J Korzeniewski; Elizabeth N Allred; T Michael O'Shea; Tim Heeren; Jean A Frazier; Janice Ware; Deborah Hirtz; Alan Leviton; Karl Kuban
Journal:  Am J Obstet Gynecol       Date:  2016-11-12       Impact factor: 8.661

4.  Executive Dysfunction Early Postnatal Biomarkers among Children Born Extremely Preterm.

Authors:  Alan Leviton; Robert M Joseph; Raina N Fichorova; Elizabeth N Allred; H Gerry Taylor; T Michael O'Shea; Olaf Dammann
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-06       Impact factor: 4.147

5.  Neurodevelopment of extremely preterm infants who had necrotizing enterocolitis with or without late bacteremia.

Authors:  Camilia R Martin; Olaf Dammann; Elizabeth N Allred; Sonal Patel; T Michael O'Shea; Karl C K Kuban; Alan Leviton
Journal:  J Pediatr       Date:  2010-07-02       Impact factor: 4.406

6.  A survey of variable selection methods in two Chinese epidemiology journals.

Authors:  Huimin Liao; Henry S Lynn
Journal:  BMC Med Res Methodol       Date:  2010-09-29       Impact factor: 4.615

7.  Maternal low-level lead exposure and fetal growth.

Authors:  Motao Zhu; Edward F Fitzgerald; Kitty H Gelberg; Shao Lin; Charlotte M Druschel
Journal:  Environ Health Perspect       Date:  2010-05-18       Impact factor: 9.031

8.  Cognitive functioning in patients with bipolar disorder: association with depressive symptoms and alcohol use.

Authors:  Marieke J van der Werf-Eldering; Huibert Burger; Esther A E Holthausen; André Aleman; Willem A Nolen
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

Review 9.  Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men.

Authors:  Holly Hagan; Ashly E Jordan; Joshua Neurer; Charles M Cleland
Journal:  AIDS       Date:  2015-11       Impact factor: 4.177

10.  Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation.

Authors:  Matthew Laughon; Michael T O'Shea; Elizabeth N Allred; Carl Bose; Karl Kuban; Linda J Van Marter; Richard A Ehrenkranz; Alan Leviton
Journal:  Pediatrics       Date:  2009-07-20       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.